Newly-Public FinCanna Provides Investors Exposure to California’s Cannabis Industry


Ryan Allway

December 29th, 2017

Exclusive, News, Top Story


The U.S. cannabis industry is projected to exceed $50 billion by 2026, according to Cowen & Co., driven by the ongoing legalization of medical and adult-use cannabis. While Colorado and Washington State were pioneers in adult-use legalization, the upcoming legalization of recreational marijuana is expected to be a watershed moment for the industry. And, investors looking for exposure to the newly minted market have relatively few options.

In this article, we will take a closer look at California’s burgeoning cannabis industry – ahead of adult-use cannabis legalization on January 1, 2018 – and how the newly-public FinCanna Capital Corp. (CSE: CALI) is positioned to capitalize on the market.

The Land of Opportunity

California is widely expected to become the largest single cannabis market in the world next year after it legalizes adult-use cannabis. Tom Adams, Editor in Chief of Arcview Market Research, recently told Bloomberg that the firm believes that the state’s legal cannabis sales could grow from $1.8 billion last year to $5.8 billion by 2021. These legal cannabis sales are expected to generate upwards of $440 million in tax revenue next year.

Earlier this month, the state issued 20 temporary licenses with less than 20 days to go until legal sales begin on January 1, 2018. While the state has permitted medical marijuana sales for about two decades, there were no standardized regulations governing the market. The introduction of new regulations on both medical and adult-use cannabis could force existing businesses to obtain new permits and comply with new regulations.

These changes have opened the door to established cannabis companies with experience operating in states where the drug is already heavily regulated, such as Colorado or Washington State. At the same time, the rush to buy land in at least two counties has increased prices by about 30% to 40%, according to a report in the North Bay Business Journal. Only a handful of municipalities have openly embraced the industry with open arms.

FinCanna’s Unique Angle

FinCanna Capital Corp. is a royalty company for licensed medical cannabis that is focused on California burgeoning market. With a team of finance and industry experts at the helm, the company is building its portfolio of investments in scalable, best-in-class projects. The goal is to build an investment vehicle for investors seeking diversified exposure to the burgeoning medical cannabis industry, particularly in states like California.

The company’s flagship investment is in Cultivation Technologies Inc. (CTI) to provide funding for its full-entitled, large-scale indoor medical cannabis facility to be developed in Coachella in Southern California. The 111,500 sq. ft. state-of-the-art facility facility will include cultivation, extraction, manufacturing, testing, and distribution capabilities.

CTI’s multi-tier growing system will include proprietary LED, racking, and irrigation systems designed to improve yields and reduce energy usage compared to linear HPS setups. In addition, the controlled environment with protocols for chemical-pesticide free cultivation to  ensure maximum safety, yield, and plant health. And, the gas-tight rooms will minimize crop loss and ensure high quality standards for medical grade product.

Additionally, CTI has established an interim medical cannabis extraction facility on the Coachella property. The lab is producing medical extracts for sale, and is expected to remain in operation during the construction of the Coachella Campus. FinCanna is entitled to receive 50% of the profits from the interim extraction facility which has been operational since October 2017.

Looking Ahead

FinCanna Capital Corp. (CSE: CALI) aims to capitalize on California’s newly legalized adult-use medical cannabis industry through its investment in Cultivation Technologies Inc., a 111,500 sq. ft. state of the art facility that will host a planned end-to-end licensed medical cannabis cultivation and distribution presence in Coachella. The company continues to pursue additional investment opportunities in best in class businesses in the US licensed medical cannabis sector, seeking to align its interests with enterprise owners and operators for a percentage of their revenues.

For more information, visit the company’s website at www.fincannacapital.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading